Velocity Clinical Research - Savannah

The trials here

What the 10 trials at this site are about, from their registry records.

Conditions

• Migraine2 trials
• Obesity2 trials
• Chronic kidney disease1 trial
• Diabetic neuropathy1 trial
• Irritable bowel syndrome1 trial
• Long COVID and ME/CFS1 trial
• Postural tachycardia syndrome (POTS)1 trial
• Psoriasis1 trial
• Type 2 diabetes1 trial

Phase

• Phase 35 trials
• Phase 23 trials
• Phase 1/21 trial
• Phase 41 trial

Status

• Active, not recruiting3 trials
• Recruiting3 trials
• Completed2 trials
• Terminated2 trials

Lead sponsor

• Amgen1 trial
• Bayer1 trial
• Biohaven Therapeutics Ltd.1 trial
• Bristol-Myers Squibb1 trial
• CinPhloro Pharma, LLC1 trial
• and 5 more

Running trials

• Recruiting

  A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  NCT07816367· Phase 3· TriGemX Bio, Inc.· Source

  Contact: Paul Bradley

• Recruiting

  Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

  NCT07231419· Phase 3· Vertex Pharmaceuticals Incorporated· Source

• Recruiting

  Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

  NCT07116967· Phase 3· Bristol-Myers Squibb· Source

  Contact: Paul Bradley, Site 0419

• Active, not recruiting

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· Phase 3· Amgen· Source

• Active, not recruiting

  Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)

  NCT06098079· Phase 4· Currax Pharmaceuticals· Source

• Active, not recruiting

  A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults

  NCT05164094· Phase 1/2· ModernaTX, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Diabetic neuropathy1 recruiting
• Migraine1 recruiting
• Psoriasis1 recruiting

Closed trials

• Completed

  Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine

  NCT06603623· Phase 2· Biohaven Therapeutics Ltd.· Source

• Terminated

  Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS

  NCT06524739· Phase 3· CSL Behring· Source

• Terminated

  Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).

  NCT06153420· Phase 2· CinPhloro Pharma, LLC· Source

• Completed

  A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes

  NCT05254002· Phase 2· Bayer· Source